FTXH vs. BBH

Last updated Jul 15, 2026

FTXH (First Trust Nasdaq Pharmaceuticals ETF) and BBH (VanEck Vectors Biotech ETF) are both Health & Biotech Equities funds - FTXH tracks the Nasdaq U.S. Smart Pharmaceuticals Index while BBH tracks the MVIS US Listed Biotech 25 Index. Both are passively managed. Over the past 5 years, FTXH returned 9.49%/yr vs 1.14%/yr for BBH. A 0.65 correlation means they provide meaningful diversification when combined. FTXH charges 0.60%/yr vs 0.35%/yr for BBH.

Performance

FTXH vs. BBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) and VanEck Vectors Biotech ETF (BBH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FTXH achieves a 14.98% return, which is significantly higher than BBH's 7.17% return.

FTXH

• 1D: -1.37%
• 1M: 4.98%
• 6M: 13.43%
• YTD: 14.98%
• 1Y: 43.98%
• 3Y*: 14.85%
• 5Y*: 9.49%
• 10Y*: —

BBH

• 1D: -0.80%
• 1M: 8.14%
• 6M: 5.70%
• YTD: 7.17%
• 1Y: 28.40%
• 3Y*: 9.45%
• 5Y*: 1.14%
• 10Y*: 6.90%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FTXH vs. BBH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FTXH First Trust Nasdaq Pharmaceuticals ETF	14.98%	24.15%	2.98%	-1.41%	2.55%	6.14%	11.73%	22.13%	-9.51%	19.44%
BBH VanEck Vectors Biotech ETF	7.17%	21.18%	-4.29%	3.94%	-15.25%	11.81%	22.13%	26.34%	-10.70%	16.46%

Correlation

The correlation between FTXH and BBH is 0.87, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.87
Correlation (3Y) Calculated over the trailing 3-year period	0.85
Correlation (5Y) Calculated over the trailing 5-year period	0.76
Correlation (All Time) Calculated using the full available price history since Sep 22, 2016	0.65

Over the past year, FTXH and BBH have become more correlated (0.87) than their long-term average of 0.65, meaning their price movements have been converging.

FTXH vs. BBH - Sectors Allocation Comparison

Sectors	FTXH	BBH
Healthcare	100.0%	100.0%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

FTXH vs. BBH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FTXH

FTXH Risk / Return Rank: 92
FTXH Sharpe Ratio Rank: 92
FTXH Sortino Ratio Rank: 93
FTXH Omega Ratio Rank: 87
FTXH Calmar Ratio Rank: 95
FTXH Martin Ratio Rank: 92

BBH

BBH Risk / Return Rank: 55
BBH Sharpe Ratio Rank: 53
BBH Sortino Ratio Rank: 55
BBH Omega Ratio Rank: 49
BBH Calmar Ratio Rank: 68
BBH Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FTXH vs. BBH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FTXH	BBH	Difference
Sharpe ratio: Return per unit of total volatility	2.51	1.45	+1.06
Sortino ratio: Return per unit of downside risk	3.72	2.15	+1.57
Omega ratio: Gain probability vs. loss probability	1.42	1.25	+0.17
Calmar ratio: Return relative to maximum drawdown	5.92	2.71	+3.21
Martin ratio: Return relative to average drawdown	17.38	6.50	+10.88

FTXH vs. BBH - Sharpe Ratio Comparison

The current FTXH Sharpe Ratio is 2.51, which is higher than the BBH Sharpe Ratio of 1.45. The chart below compares the historical Sharpe Ratios of FTXH and BBH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

FTXH vs. BBH - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum BBH drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for FTXH and BBH.

Drawdown Indicators

	FTXH	BBH	Difference
Max Drawdown Largest peak-to-trough decline	-32.11%	-72.70%	+40.59%
Max Drawdown (1Y) Largest decline over 1 year	-7.47%	-10.55%	+3.08%
Max Drawdown (3Y) Largest decline over 3 years	-19.51%	-22.74%	+3.23%
Max Drawdown (5Y) Largest decline over 5 years	-19.51%	-39.86%	+20.35%
Max Drawdown (10Y) Largest decline over 10 years	—	-39.86%	—
Current Drawdown Current decline from peak	-4.40%	-5.89%	+1.49%
Average Drawdown Average peak-to-trough decline	-5.78%	-20.70%	+14.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.55%	4.38%	-1.83%

Volatility

FTXH vs. BBH - Volatility Comparison

First Trust Nasdaq Pharmaceuticals ETF (FTXH) and VanEck Vectors Biotech ETF (BBH) have volatilities of 5.70% and 5.77%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FTXH	BBH	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.70%	5.77%	-0.07%
Volatility (6M) Calculated over the trailing 6-month period	12.56%	14.71%	-2.15%
Volatility (1Y) Calculated over the trailing 1-year period	17.63%	19.71%	-2.08%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.51%	21.57%	-5.06%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.44%	22.10%	-3.66%

FTXH vs. BBH - Expense Ratio Comparison

FTXH has a 0.60% expense ratio, which is higher than BBH's 0.35% expense ratio.

Dividends

FTXH vs. BBH - Dividend Comparison

FTXH's dividend yield for the trailing twelve months is around 1.12%, more than BBH's 0.47% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBH VanEck Vectors Biotech ETF	0.47%	0.51%	0.80%	0.43%	0.47%	0.21%	0.36%	0.34%	0.50%	0.55%	0.30%	0.27%
FTXH First Trust Nasdaq Pharmaceuticals ETF	1.12%	1.41%	1.66%	1.55%	1.11%	1.03%	0.82%	0.67%	0.91%	2.18%	0.19%	0.00%

Frequently Asked Questions

Can I hold both FTXH and BBH in my portfolio?

FTXH and BBH have a correlation of 0.87, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FTXH or BBH?

BBH has higher volatility (5.77%) compared to FTXH (5.70%). In terms of maximum drawdown, FTXH dropped -32.11% vs BBH's -72.70%.

Which ETF is better, FTXH or BBH?

On 5-year performance, FTXH leads with 9.49% vs 1.14% for BBH. On fees, BBH is cheaper at 0.35% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, FTXH or BBH?

Over the 5-year period, FTXH has performed better with a 9.49% return vs 1.14%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, FTXH or BBH?

BBH is cheaper with a 0.35% expense ratio, compared with 0.60% for FTXH.

Which ETF pays a higher dividend yield, FTXH or BBH?

FTXH has the higher dividend yield at 1.12%, compared with 0.47% for BBH.

What is the main difference between FTXH and BBH?

FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while BBH tracks MVIS US Listed Biotech 25 Index. They also come from different issuers: First Trust and VanEck. Their fees differ too: 0.60% for FTXH and 0.35% for BBH.

Which has better risk-adjusted returns?

FTXH currently has the higher Sharpe Ratio (2.51 vs 1.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.